IRIS
PEROSA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.849
EU - Europa 2.206
AS - Asia 714
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
AF - Africa 1
SA - Sud America 1
Totale 10.785
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.841
CN - Cina 635
IT - Italia 523
SE - Svezia 517
UA - Ucraina 396
DE - Germania 275
FI - Finlandia 198
GB - Regno Unito 130
FR - Francia 66
IN - India 39
IE - Irlanda 32
BE - Belgio 24
VN - Vietnam 16
PL - Polonia 13
CA - Canada 7
EU - Europa 7
IR - Iran 7
AU - Australia 6
HR - Croazia 6
NL - Olanda 6
SG - Singapore 5
TR - Turchia 4
ID - Indonesia 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
DK - Danimarca 2
MD - Moldavia 2
RU - Federazione Russa 2
AL - Albania 1
BG - Bulgaria 1
BZ - Belize 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IM - Isola di Man 1
JP - Giappone 1
KH - Cambogia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
Totale 10.785
Salva come PNG Salva come JPEG
Città #
Jacksonville 940
Chandler 936
Fairfield 860
Woodbridge 666
Houston 521
Ashburn 481
Ann Arbor 396
Nyköping 384
Cambridge 355
Seattle 349
Wilmington 324
Bari 263
Lawrence 203
Nanjing 202
Roxbury 200
Des Moines 134
Beijing 129
New York 113
Boardman 91
Princeton 90
Inglewood 66
Nanchang 57
Shenyang 52
Hebei 48
San Diego 40
Brooklyn 37
Pune 35
Jiaxing 30
Tianjin 28
Changsha 25
Dublin 25
London 25
Brussels 24
Noicattaro 23
Los Angeles 22
Paris 19
Dong Ket 16
Dearborn 15
Marseille 15
Rome 15
Falls Church 14
Grafing 14
Washington 13
Auburn Hills 12
Radomsko 12
Milan 8
Norwalk 8
Redwood City 8
Ardabil 7
Hefei 7
Jinan 7
Leawood 7
Ningbo 7
Guangzhou 6
Helsinki 6
Indiana 6
Kilburn 6
Kunming 6
San Francisco 6
Sydney 6
San Mateo 5
Singapore 5
Taizhou 5
Zhengzhou 5
Amsterdam 4
Chiswick 4
Redmond 4
Triggiano 4
Aci Castello 3
Augusta 3
Chicago 3
Edinburgh 3
Florence 3
Martina Franca 3
Monmouth Junction 3
Mugla 3
Naples 3
Napoli 3
Pescara 3
Prescot 3
Waterford 3
Acquaviva Picena 2
Arzano 2
Bologna 2
Canosa Di Puglia 2
Catanzaro 2
Centro 2
Copenhagen 2
Francavilla al Mare 2
Frankfurt am Main 2
Fuzhou 2
Gravina In Puglia 2
Haikou 2
Hounslow 2
Minervino Murge 2
Montreal 2
New Bedfont 2
Pordenone 2
Qingdao 2
Salzkotten 2
Totale 8.533
Salva come PNG Salva come JPEG
Nome #
null 135
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 118
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 117
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 115
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 115
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 110
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 107
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 103
Autoantibodies to intracellular antigens: generation and pathogenetic role 101
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 100
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 100
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 99
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 99
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 98
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 97
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 93
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 92
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 91
Serological methods to detect anti-idiotypic antibodies 89
Vasculitides: Proposal for an integrated nomenclature 89
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 87
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 86
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 86
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affette da patologia autoimmune immunizzate con un anticorpo monoclonale anti-idiotipo (AcMo2) 85
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 84
Rheumatic disorders as paraneoplastic syndromes 83
Extra-articular manifestations of rheumatoid arthritis: an update 82
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 81
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 81
null 81
CD20: A target antigen for immunotherapy of autoimmune diseases 80
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 79
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3) 79
null 77
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 77
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 76
null 76
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 75
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 75
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 74
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 74
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 74
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 73
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 72
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 72
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 72
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 70
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 69
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 67
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 67
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 67
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 66
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 66
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 66
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 65
Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? 65
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 62
null 62
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 61
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 61
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 61
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 61
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 61
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti-human high molecular weight-melanoma associated antigen and anti-HLA monoclonal antibodies 60
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 59
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 59
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 59
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 58
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 58
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affetti da patologia autoimmune, immunizzati con un anticorpo monoclonale anti-idiotipo (AcMo2) "Immagine Interna" dell'antigene CD4 56
Antigenic mimicry by linear peptides of the conformational epitope recognized by the anti-CD20 monoclonal antibody (mAb) Rituximab 55
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 55
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 55
Studi in vitro dell'attivita' antiallergica del Fenoterolo 54
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 54
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 54
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 54
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 54
Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens 53
Antigene CD4 solubile nei preparati di immunoglobuline umane per vie endovenosa 53
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 53
Vaccination against CD20 mimotope peptiide. Is it a feasible strategy for the treatment of autoimmune diseases? 52
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 52
Anticorpi monoclonali anti-idiotipo (Ab2) anti-CD4 inducono anticorpi anti-CD4 in un sistema singenico 52
Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope 52
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies and identifies a subset of anti-CENP antibody positive systemic sclerosis patients 51
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 51
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 51
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 51
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 50
Syngeneic anti-idiotipyc monoclonal antibodies that bear the internal image of HLA-DR antigen 50
Syngeneic antiidiotypic monoclonal antibodies to murine anti human high molecular weight-melanoma associated antigen monoclonal antibodies 50
Anticorpi singenici poli e monoclonali anti-idiotipo (Ab2) specifici per un AcMo murino anti-CD4 HP2/6 50
Analysis of beta-2 microglobulin (b2M), free HLA class I heavy chain (FHC) and the associated protein pattern in multiple myeloma (MM) patients from the Nordic Myeloma Group Study #5/94. Haematologica-the Hematology Journal 50
Vasculiti primarie sistemiche 50
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 49
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 48
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 48
Uso di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 47
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN MONOCYTES FROM PATIENTS WITH SYSTEMIC SCLEROSIS AND CORRELATION WITH THEIR SEROLOGICAL PROFILE 47
Totale 7.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019516 0 0 0 0 0 0 0 0 0 0 238 278
2019/20202.480 502 176 53 156 305 150 265 141 294 125 277 36
2020/20211.905 214 42 203 63 256 95 261 110 228 220 133 80
2021/20221.424 63 214 8 80 77 71 110 87 64 42 237 371
2022/20232.351 343 206 115 229 327 341 37 270 366 28 53 36
2023/2024749 64 148 43 93 65 223 25 66 6 16 0 0
Totale 11.089